O
Olivier F. Bertrand
Researcher at Laval University
Publications - 509
Citations - 37435
Olivier F. Bertrand is an academic researcher from Laval University. The author has contributed to research in topics: Percutaneous coronary intervention & Conventional PCI. The author has an hindex of 81, co-authored 495 publications receiving 33555 citations. Previous affiliations of Olivier F. Bertrand include Paris Diderot University & French Institute of Health and Medical Research.
Papers
More filters
Journal ArticleDOI
Transient Myocardial Tissue and Function Changes During a Marathon in Less Fit Marathon Runners
Valérie Gaudreault,Helena Tizón-Marcos,Paul Poirier,Philippe Pibarot,Philippe Gilbert,Marc Amyot,Josep Rodés-Cabau,Jean-Pierre Després,Olivier F. Bertrand,Eric Larose +9 more
TL;DR: In this article, the authors studied 20 recreational marathon runners without known cardiovascular disease or symptoms: at peak training before, immediately after, and 3 months after a 42.2km marathon.
Journal ArticleDOI
Brain responses to success and failure: Direct recordings from human cerebral cortex
Julien Jung,Karim Jerbi,Karim Jerbi,Tomás Ossandón,Philippe Ryvlin,Jean Isnard,Olivier F. Bertrand,Marc Guénot,Marc Guénot,François Mauguière,Jean-Philippe Lachaux +10 more
TL;DR: These findings show that evaluating the outcome of the authors' actions triggers γ‐range activity modulations in several frontal and insular regions, and reveal fine‐scale dissociations between the neural dynamics of positive versus negative feedback processing.
Journal ArticleDOI
Plasminogen Paris I: Congenital abnormal plasminogen and its incidence in thrombosis
TL;DR: The experimental findings can be explained by assuming that half of the plasminogen is normal, while the other half is an inactive mutant protein, without catalytic activity after SK or UK addition.
Journal ArticleDOI
Treatment of functional mitral valve regurgitation with the permanent percutaneous transvenous mitral annuloplasty system: Results of the multicenter international Percutaneous Transvenous Mitral Annuloplasty System to Reduce Mitral Valve Regurgitation in Patients with Heart Failure trial
Jimmy MacHaalany,Luc Bilodeau,Rainer Hoffmann,Stefan Sack,Horst Sievert,Josef Kautzner,Christoph Hehrlein,Patrick W. Serruys,Mario Sénéchal,Pamela S. Douglas,Olivier F. Bertrand +10 more
TL;DR: Overall, PTMA had mild impact on MR reduction, left ventricular remodeling, QOL, and exercise capacity, and the risk/benefit ratio remained suboptimal.
Patent
Radioactivity local delivery system
TL;DR: In this paper, a radioisotope coupled to a circulation time reducing agent such as a chelatin agent is used to decrease the growth of actively proliferating cells at a targeted site in a vessel of a human patient.